• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年慢性肾脏病患者动脉粥样硬化性肾动脉狭窄的超声评估:一项意大利队列研究

Ultrasonographic Assessment of Atherosclerotic Renal Artery Stenosis in Elderly Patients with Chronic Kidney Disease: An Italian Cohort Study.

作者信息

Battaglia Yuri, Fiorini Fulvio, Gisonni Pietro, Imbriaco Massimo, Lentini Paolo, Zeiler Matthias, Russo Luigi, Prencipe Michele, Russo Domenico

机构信息

Department of Medicine, University of Verona, 37129 Verona, Italy.

Nephrology and Dialysis Unit, Pederzoli Hospital, 37019 Peschiera del Garda, Italy.

出版信息

Diagnostics (Basel). 2022 Jun 13;12(6):1454. doi: 10.3390/diagnostics12061454.

DOI:10.3390/diagnostics12061454
PMID:35741264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9222028/
Abstract

Although atherosclerotic renal artery stenosis (ARAS) is strictly associated with high cardiovascular risk and mortality, it often may remain unrecognized being clinically silent and frequently masked by co-morbidities especially in elderly patients with coexisting chronic kidney disease (CKD). The present observational study was conducted in elderly CKD-patients with atherosclerosis on other arterial beds. The aims were assessment of (1) ARAS prevalence; (2) best predictor(s) of ARAS, using duplex ultrasound; and (3) cardiovascular and renal outcomes at one-year follow-up. The cohort was represented by 607 consecutive in-patients. Inclusion criteria were age ≥65 years; CKD stages 2−5 not on dialysis; single or multiple atherosclerotic plaque on epiaortic vessels, abdominal aorta, aortic arch, coronary arteries, peripheral arteries that had been previously ascertained by one or more procedures. Duplex ultrasound was used to detect ARAS. Multiple regression analysis and ROS curve were performed to identify the predictors of ARAS. ARAS was found in 53 (44%) out of 120 patients who met the inclusion criteria. In univariate analysis, GFR (b = −0.021; p = 0.02); hemoglobin (b = −0.233; p = 0.02); BMI (b = 0.134; p = 0.036) and atherosclerosis of abdominal aorta and/or peripheral vessels (b = 1.025; p < 0.001) were associated with ARAS. In multivariable analysis, abdominal aorta and/or peripheral atherosclerosis was a significant (p = 0.002) predictor of ARAS. The area under the ROC curve was 0.655 (C.I. = 0.532−0.777; p = 0.019). ARAS is common in older CKD patients with extra-renal atherosclerosis, with the highest prevalence in those with aortic and peripheral atherosclerosis. ARAS may pass by unnoticed in everyday clinical practice.

摘要

尽管动脉粥样硬化性肾动脉狭窄(ARAS)与高心血管风险及死亡率密切相关,但它常常未被识别,因为其在临床上没有症状,且常被合并症掩盖,尤其是在同时患有慢性肾脏病(CKD)的老年患者中。本观察性研究针对其他动脉床存在动脉粥样硬化的老年CKD患者开展。目的是评估:(1)ARAS的患病率;(2)使用双功超声评估ARAS的最佳预测指标;(3)随访一年时的心血管和肾脏结局。该队列由607例连续住院患者组成。纳入标准为:年龄≥65岁;CKD 2 - 5期且未接受透析;经一种或多种检查确定在主动脉弓、腹主动脉、冠状动脉、外周动脉存在单发或多发动脉粥样硬化斑块。使用双功超声检测ARAS。进行多元回归分析和ROC曲线分析以确定ARAS的预测指标。在符合纳入标准的120例患者中,有53例(44%)发现有ARAS。单因素分析中,肾小球滤过率(b = -0.021;p = 0.02)、血红蛋白(b = -0.233;p = 0.02)、体重指数(b = 0.134;p = 0.036)以及腹主动脉和/或外周血管的动脉粥样硬化(b = 1.025;p < 0.001)与ARAS相关。多因素分析中,腹主动脉和/或外周动脉粥样硬化是ARAS的显著预测指标(p = 0.002)。ROC曲线下面积为0.655(C.I. = 0.532 - 0.777;p = 0.019)。ARAS在合并肾外动脉粥样硬化的老年CKD患者中很常见,在主动脉和外周动脉粥样硬化患者中患病率最高。在日常临床实践中,ARAS可能未被注意到。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdac/9222028/24dc3ee634a4/diagnostics-12-01454-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdac/9222028/f7d8689bd708/diagnostics-12-01454-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdac/9222028/24dc3ee634a4/diagnostics-12-01454-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdac/9222028/f7d8689bd708/diagnostics-12-01454-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdac/9222028/24dc3ee634a4/diagnostics-12-01454-g002.jpg

相似文献

1
Ultrasonographic Assessment of Atherosclerotic Renal Artery Stenosis in Elderly Patients with Chronic Kidney Disease: An Italian Cohort Study.老年慢性肾脏病患者动脉粥样硬化性肾动脉狭窄的超声评估:一项意大利队列研究
Diagnostics (Basel). 2022 Jun 13;12(6):1454. doi: 10.3390/diagnostics12061454.
2
The impact of renal artery stenosis on outcomes after open-heart surgery.肾动脉狭窄对心脏直视手术后结局的影响。
J Am Coll Cardiol. 2014 Feb 4;63(4):310-6. doi: 10.1016/j.jacc.2013.09.046. Epub 2013 Oct 23.
3
Prevalence and predictors of renal artery stenosis in patients undergoing peripheral and coronary angiography.在接受外周血管和冠状动脉造影的患者中,肾动脉狭窄的患病率和预测因素。
Int Urol Nephrol. 2013 Dec;45(6):1629-35. doi: 10.1007/s11255-013-0435-x. Epub 2013 Apr 16.
4
Atherosclerotic renal artery stenosis is prevalent in cardiorenal patients but not associated with left ventricular function and myocardial fibrosis as assessed by cardiac magnetic resonance imaging.动脉粥样硬化性肾动脉狭窄在心脏肾脏患者中较为普遍,但通过心脏磁共振成像评估,与左心室功能和心肌纤维化无关。
BMC Cardiovasc Disord. 2012 Sep 18;12:76. doi: 10.1186/1471-2261-12-76.
5
Long-term follow-up of patients with atherosclerotic renal artery disease.动脉粥样硬化性肾动脉疾病患者的长期随访
J Am Soc Hypertens. 2013 Jan-Feb;7(1):24-31. doi: 10.1016/j.jash.2012.12.001.
6
Prevalence and predictors of renal artery stenosis in Chinese patients with coronary artery disease.中国冠心病患者肾动脉狭窄的患病率及预测因素
Intern Med J. 2003 Jul;33(7):280-5. doi: 10.1046/j.1445-5994.2003.00396.x.
7
Correlation of atherosclerotic renal artery stenosis with extracranial carotid and intracranial cerebral artery atherosclerosis in patients with ischemic stroke.缺血性脑卒中患者动脉粥样硬化性肾动脉狭窄与颅外颈动脉及颅内脑动脉粥样硬化的相关性
Blood Press. 2013 Oct;22(5):312-6. doi: 10.3109/08037051.2013.765635. Epub 2013 Feb 7.
8
[Prevalence and risk factors of atherosclerotic renal artery stenosis].[动脉粥样硬化性肾动脉狭窄的患病率及危险因素]
Zhonghua Yi Xue Za Zhi. 2013 Mar 19;93(11):827-31.
9
Prevalence and risk factors of atherosclerotic renal artery stenosis in 1,200 chinese patients undergoing coronary angiography.1200例接受冠状动脉造影的中国患者中动脉粥样硬化性肾动脉狭窄的患病率及危险因素
Nephron Clin Pract. 2006;104(4):c185-92. doi: 10.1159/000095854. Epub 2006 Sep 22.
10
Prophylactic repair of renal artery stenosis is not justified in patients who require infrarenal aortic reconstruction.对于需要进行肾下主动脉重建的患者,预防性修复肾动脉狭窄是不合理的。
J Vasc Surg. 1998 Jul;28(1):14-20; discussion 20-2. doi: 10.1016/s0741-5214(98)70195-8.

引用本文的文献

1
Predictors of high-grade atherosclerotic renal artery stenosis in patients with CKD.慢性肾脏病患者中高级别动脉粥样硬化性肾动脉狭窄的预测因素
Medicine (Baltimore). 2024 Dec 27;103(52):e41007. doi: 10.1097/MD.0000000000041007.
2
Association of ACEI/ARB therapy with total and cardiovascular death in coronary artery disease patients with advanced chronic kidney disease: a large multi-center longitudinal study.在伴有晚期慢性肾病的冠状动脉疾病患者中,ACEI/ARB 治疗与全因和心血管死亡的相关性:一项大型多中心纵向研究。
Ren Fail. 2024 Dec;46(2):2398189. doi: 10.1080/0886022X.2024.2398189. Epub 2024 Sep 4.
3
Peripheral Artery Disease Ultrasound Assessment in Predicting the Severity of Coronary Artery Disease.

本文引用的文献

1
[Physical exercise in chronic kidney disease: an empty narrative or an effective intervention?].[慢性肾脏病中的体育锻炼:空洞的叙述还是有效的干预措施?]
G Ital Nefrol. 2021 Dec 16;38(6):2021-vol6.
2
Atherosclerotic Renal Artery Stenosis: A Review.动脉粥样硬化性肾动脉狭窄:综述
Aorta (Stamford). 2021 Jun;9(3):95-99. doi: 10.1055/s-0041-1730004. Epub 2021 Oct 12.
3
Atherosclerotic Renovascular Disease: A KDIGO (Kidney Disease: Improving Global Outcomes) Controversies Conference.动脉粥样硬化性肾血管疾病:KDIGO(肾脏病:改善全球预后)争议会议。
外周动脉疾病超声评估对冠状动脉疾病严重程度的预测作用
Life (Basel). 2024 Mar 1;14(3):333. doi: 10.3390/life14030333.
4
Application of simple ultrasound Doppler hemodynamic parameters in the diagnosis of severe renal artery stenosis in routine clinical practice.简单超声多普勒血流动力学参数在常规临床实践中诊断重度肾动脉狭窄的应用。
Quant Imaging Med Surg. 2023 Dec 1;13(12):8042-8052. doi: 10.21037/qims-23-605. Epub 2023 Oct 19.
5
Does Renal Denervation a Reasonable Treatment Option in Hemodialysis-Dependent Patient with Resistant Hypertension? A Narrative Review.肾去神经术在透析依赖的难治性高血压患者中是否是一种合理的治疗选择?一项叙述性综述。
Curr Hypertens Rep. 2023 Nov;25(11):353-363. doi: 10.1007/s11906-023-01264-2. Epub 2023 Sep 6.
6
Psychosocial determinants of healthcare use costs in kidney transplant recipients.肾移植受者医疗利用成本的社会心理决定因素。
Front Public Health. 2023 Jun 2;11:1158387. doi: 10.3389/fpubh.2023.1158387. eCollection 2023.
7
The Impact of Cholecaciferol Supplementation on Bone Mineral Density in Long-Term Kidney Transplant Recipients.维生素 D 补充对长期肾移植受者骨密度的影响。
Biomolecules. 2023 Mar 31;13(4):629. doi: 10.3390/biom13040629.
Am J Kidney Dis. 2022 Feb;79(2):289-301. doi: 10.1053/j.ajkd.2021.06.025. Epub 2021 Aug 9.
4
Central and peripheral arterial diseases in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.慢性肾脏病中的中心和外周动脉疾病:来自肾脏病:改善全球预后(KDIGO)争议会议的结论。
Kidney Int. 2021 Jul;100(1):35-48. doi: 10.1016/j.kint.2021.04.029. Epub 2021 May 5.
5
Ultrasound Methods in the Evaluation of Atherosclerosis: From Pathophysiology to Clinic.超声评估动脉粥样硬化的方法:从病理生理学到临床应用
Biomedicines. 2021 Apr 13;9(4):418. doi: 10.3390/biomedicines9040418.
6
Renal artery stenosis.肾动脉狭窄。
Prog Cardiovasc Dis. 2021 Mar-Apr;65:60-70. doi: 10.1016/j.pcad.2021.03.003. Epub 2021 Mar 18.
7
The Role of Prognostic and Predictive Biomarkers for Assessing Cardiovascular Risk in Chronic Kidney Disease Patients.慢性肾脏病患者心血管风险评估的预后和预测生物标志物的作用。
Biomed Res Int. 2020 Oct 8;2020:2314128. doi: 10.1155/2020/2314128. eCollection 2020.
8
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.2019年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理指南:通过血脂修饰降低心血管风险
Eur Heart J. 2020 Jan 1;41(1):111-188. doi: 10.1093/eurheartj/ehz455.
9
Recommendations for ultrasonographic assessment of renal arteries.肾动脉超声评估建议。
J Ultrason. 2018;18(75):338-343. doi: 10.15557/JoU.2018.0049.
10
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS).2017年欧洲心脏病学会(ESC)与欧洲血管外科学会(ESVS)合作制定的外周动脉疾病诊断和治疗指南:涵盖颅外颈动脉和椎动脉、肠系膜、肾、上肢和下肢动脉粥样硬化疾病的文件 认可机构:欧洲卒中组织(ESO) 欧洲心脏病学会(ESC)和欧洲血管外科学会(ESVS)外周动脉疾病诊断和治疗特别工作组
Eur Heart J. 2018 Mar 1;39(9):763-816. doi: 10.1093/eurheartj/ehx095.